<?xml version="1.0" encoding="UTF-8"?>
<p>Another interesting case could be made for fecal microbiota transplant (FMT), a clearly known effective treatment for recurrent 
 <italic>Clostridium difficile</italic> infections.
 <sup>
  <xref rid="CIT0095" ref-type="bibr">95</xref>, 
  <xref rid="CIT0096" ref-type="bibr">96</xref>
 </sup> In December 2019, the consensus report on stool banking for microbiota transplantation was released, where specific recommendations about stool donor screening were made.
 <sup>
  <xref rid="CIT0097" ref-type="bibr">97</xref>
 </sup> Given the increasing evidence of a potential gastrointestinal involvement in SARS-CoV-2 infection and the possible existence of a fecal-oral route of transmission, several measures have been updated to assure the best safety possible against COVID-19 transmission through FMT.
</p>
